Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6533 | 1404 | 34.2 | 61% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 380 | 16446 | STREPTOCOCCUS PNEUMONIAE//COMMUNITY ACQUIRED PNEUMONIA//PNEUMOCOCCAL CONJUGATE VACCINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PNEUMOCOCCAL POLYSACCHARIDE VACCINE | Author keyword | 23 | 45% | 3% | 39 |
| 2 | PNEUMOCOCCAL VACCINE | Author keyword | 16 | 24% | 4% | 59 |
| 3 | 23 VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE | Author keyword | 10 | 61% | 1% | 11 |
| 4 | POLYSACCHARIDE PNEUMOCOCCAL VACCINE | Author keyword | 6 | 71% | 0% | 5 |
| 5 | PRIMARY CARE SERV TARRAGONA VALLS | Address | 6 | 50% | 1% | 9 |
| 6 | PNEUMOCOCCAL VACCINATION | Author keyword | 5 | 19% | 2% | 23 |
| 7 | C POLYSACCHARIDE | Author keyword | 5 | 55% | 0% | 6 |
| 8 | VACCINE IMMUNOL | Address | 5 | 44% | 1% | 8 |
| 9 | VACCINES SECT | Address | 4 | 67% | 0% | 4 |
| 10 | PNEUMOCOCCAL | Author keyword | 4 | 15% | 2% | 27 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | POLYSACCHARIDE VACCINE | 46 | 22% | 13% | 181 |
| 2 | 23F POLYSACCHARIDES | 18 | 83% | 1% | 10 |
| 3 | C POLYSACCHARIDE | 16 | 35% | 3% | 38 |
| 4 | FUNCTIONAL ANTIBODY ACTIVITY | 15 | 77% | 1% | 10 |
| 5 | SECRETING CELL RESPONSE | 12 | 86% | 0% | 6 |
| 6 | CELL WALL POLYSACCHARIDE | 10 | 26% | 2% | 33 |
| 7 | REFERENCE SERUM | 9 | 55% | 1% | 11 |
| 8 | 6B | 8 | 52% | 1% | 11 |
| 9 | CAPSULAR POLYSACCHARIDE VACCINE | 8 | 21% | 2% | 34 |
| 10 | REVACCINATION | 8 | 17% | 3% | 43 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Vaccines for preventing pneumococcal infection in adults | 2008 | 145 | 56 | 77% |
| Vaccines for preventing pneumococcal infection in adults | 2013 | 15 | 68 | 78% |
| Use of opsonophagocytosis for serological evaluation of pneurnococcal vaccines | 2006 | 73 | 16 | 75% |
| Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe | 2011 | 37 | 109 | 54% |
| Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? | 2007 | 103 | 56 | 39% |
| Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults | 2002 | 83 | 31 | 61% |
| Preventing Pneumococcal Disease in the Elderly | 2013 | 11 | 93 | 54% |
| The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials | 2004 | 63 | 41 | 61% |
| Pneumococcal vaccination in adults: Does it really work? | 2011 | 15 | 65 | 71% |
| Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence | 2003 | 67 | 39 | 77% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PRIMARY CARE SERV TARRAGONA VALLS | 6 | 50% | 0.6% | 9 |
| 2 | VACCINE IMMUNOL | 5 | 44% | 0.6% | 8 |
| 3 | VACCINES SECT | 4 | 67% | 0.3% | 4 |
| 4 | PNEUMOCOCCAL | 3 | 57% | 0.3% | 4 |
| 5 | INFEKTOL TANSZEKI CSOPORT | 2 | 67% | 0.1% | 2 |
| 6 | ZENTRUM INFEKT MED KRANKENHAUSHYG | 1 | 38% | 0.2% | 3 |
| 7 | ABORATING NEONATAL VACCINOL IMMUNOL | 1 | 100% | 0.1% | 2 |
| 8 | EGYESITETT SZENT ISTVAN SZENT LASZLO KORHAZ | 1 | 100% | 0.1% | 2 |
| 9 | INFORMAT INFECT DIS | 1 | 100% | 0.1% | 2 |
| 10 | PFIZER VACCINES | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000284029 | PNEUMOCOCCAL CONJUGATE VACCINE//INVASIVE PNEUMOCOCCAL DISEASE//STREPTOCOCCUS PNEUMONIAE |
| 2 | 0.0000152826 | LIPOSOMAL VALINOMYCIN//AGR LIFE SCI BACTERIOL//TETANUS TOXOID ANTIGEN |
| 3 | 0.0000144807 | PNEUMOLYSIN//PSPA//STREPTOCOCCUS PNEUMONIAE |
| 4 | 0.0000143591 | TL 2 RESPONSE//ADCC REACTION//ANTI IG DEXTRAN |
| 5 | 0.0000137732 | ANTIGENURIA//ANTIGEN DETECTION TESTS//CAPSULAR POLYSACCHARIDE ANTIGENS |
| 6 | 0.0000123551 | HAEMOPHILUS INFLUENZAE TYPE B//HIB//HAEMOPHILUS INFLUENZAE TYPE B VACCINE |
| 8 | 0.0000118630 | BACTERIAL PNEUMONIA//MALAWI LIVERPOOL WELLCOME PROGRAMME CLIN TROP//DPUO |
| 9 | 0.0000112588 | INFLUENZA VACCINATION//INFLUENZA VACCINE//HEALTH CARE WORKERS |
| 10 | 0.0000111248 | PENICILLIN RESISTANCE//PENICILLIN RESISTANT PNEUMOCOCCI//EENHEID ANTIBIOT ONDERZOEK |